Aprecia Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 63

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Aprecia General Information

Description

Developer of three-dimensional printing formulation platforms intended to assist patients in living healthier lives. The company offers pharmaceutical manufacturing innovation and precision formulation services, enabling three-dimensional printing production and oral drug delivery capabilities to streamline development and accelerate speed to market.

Contact Information

Website
www.aprecia.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 7200 Industrial Row Drive
  • Suite 200
  • Mason, OH 45040
  • United States
+1 (513)
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Vertical(s)
3D Printing, Manufacturing, TMT, Life Sciences
Corporate Office
  • 7200 Industrial Row Drive
  • Suite 200
  • Mason, OH 45040
  • United States
+1 (513)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aprecia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private Completed Generating Revenue
7. Secondary Transaction - Private 07-Sep-2017 Completed Generating Revenue
6. Debt - General 05-Jul-2016 Completed Generating Revenue
5. Later Stage VC (Series A) 27-Jan-2016 Completed Generating Revenue
4. Later Stage VC 10-Dec-2013 Completed Generating Revenue
3. Later Stage VC 19-Nov-2012 Completed Generating Revenue
2. Later Stage VC 04-Nov-2011 $25.7M $29.3M Completed Generating Revenue
1. Later Stage VC 25-Jan-2008 $3.63M $3.63M Completed Startup
To view Aprecia’s complete valuation and funding history, request access »

Aprecia Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A2
Series A1
MIT-2 190,951 $0.001000
MIT-1 418,548 $0.001000
To view Aprecia’s complete cap table history, request access »

Aprecia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of three-dimensional printing formulation platforms intended to assist patients in living healthier lives. The
Drug Delivery
Mason, OH
63 As of 2026

Bratislava, Slovakia
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aprecia Competitors (43)

One of Aprecia’s 43 competitors is STADA Slovakia, a Corporation company based in Bratislava, Slovakia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
STADA Slovakia Corporation Bratislava, Slovakia
Laxxon Medical Private Equity-Backed New York, NY
STADA Eurasia Corporation Almaty, Kazakhstan
Stada Croatia Corporation Zagreb, Croatia
Berlin-Chemie Corporation Berlin, Germany
You’re viewing 5 of 43 competitors. Get the full list »

Aprecia Patents

  • 181

    Total Documents Applications and Grants

  • Total Patents Families

  • 131

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

Aprecia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025085774-A1 Particulate dispensing apparatus Inactive 18-Oct-2023
WO-2025085778-A1 System and method for additive manufacturing using process analytical technology Inactive 18-Oct-2023
EP-4618958-A1 Functionally-dividable orodispersive dosage form Pending 18-Nov-2022
US-20250295593-A1 Functionally-dividable orodispersive dosage form Pending 18-Nov-2022
WO-2024108084-A1 Functionally-dividable orodispersive dosage form Inactive 18-Nov-2022 A61K9/2072
To view Aprecia’s complete patent history, request access »

Aprecia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aprecia Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Prasco (United States) Corporation Minority
To view Aprecia’s complete investors history, request access »

Ready to get started?

Request a free trial

Aprecia FAQs

  • When was Aprecia founded?

    Aprecia was founded in 2003.

  • Where is Aprecia headquartered?

    Aprecia is headquartered in Mason, OH.

  • What is the size of Aprecia?

    Aprecia has 63 total employees.

  • What industry is Aprecia in?

    Aprecia’s primary industry is Drug Delivery.

  • Is Aprecia a private or public company?

    Aprecia is a Private company.

  • What is Aprecia’s current revenue?

    The current revenue for Aprecia is .

  • How much funding has Aprecia raised over time?

    Aprecia has raised $147M.

  • Who are Aprecia’s investors?

    Prasco (United States) has invested in Aprecia.

  • Who are Aprecia’s competitors?

    STADA Slovakia, Laxxon Medical, STADA Eurasia, Stada Croatia, and Berlin-Chemie are some of the 43 competitors of Aprecia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process